Avedro said today it raised $25 million in a new round of financing, with fund slated to support further product development, clinical studies and expanding sales and reimbursement support for its products. The round was led by Lilly Asia Ventures and joined by existing investors OrbiMed Advisors, InterWest Partners and HealthQuest Capital, the Waltham, Mass.-based company […]
Medtronic taps Harvard cardiologist Mauri for clinical research VP | Personnel Moves – April 10, 2018
Medtronic (NYSE:MDT) said last week it tapped Harvard Medical School professor and cardiologist Dr. Laura Mauri as its new vice president of global clinical research and analytics. In the new position, Dr. Mauri will direct dynamic global clinical research strategies as well as the development of novel analytical and data science solutions as the Fridley, Minn.-baesd […]
Acelity taps Jokinen as CFO, exec VP | Personnel Moves June 20, 2017
Acelity said last week it tapped Tracy Jokinen as its chief financial officer and executive vice president, taking over for interim CFO Todd Wyatt. Jokinen was formerly a CFO of uniform and facility services provider G&K services, which was acquired by Cintas earlier this year. Prior to working at G&K, Jokinen spent more than 20 years at […]
Avedro raises $42m, opens new Mass-based manufacturing facility
Avedro said today it raised $42 million in equity and debt financing and opened a new manufacturing facility in Burlington, Mass. The equity financing was led by HealthQuest Capital and joined by OrbiMed Advisors and InterWest Partners, while the debt financing was supported by an affiliate of OrbiMed, the company said. “Avedro has established itself as the […]
Avedro launches KXL corneal cross-linking system
Avedro said today it launched the KXL corneal cross-linking system in the U.S., touting the 1st commercial procedure performed with the system and the associated Photexa Viscous and Photexa drugs used with the system. The company won FDA approval for the device and the associated drugs in April. The Photrexa Viscous, Photrexa and the KXL […]
Avedro taps Visiogen founder Zadno for CEO | Personnel Moves Sept. 9 2016
Avedro taps Visiogen founder Zadno for CEO Avedro said it named the founder, president of Abbott (NYSE:ABT) acquisition Visiogen, Reza Zadno, to be its new CEO. Zadno replaces CFO/COO Brian Roberts, the former CFO at Insulet (NSDQ:PODD), who stepped in on an interim basis when David Muller bowed out shortly after Avedro closed a $32 million […]
FDA approves Avedro’s KXL eye treatment
Avedro said today that it won FDA approval for its KXL corneal cross-linking eye treatment and a pair of photo enhancers used with the procedure. The pre-market approval nod for Photrexa Viscous, Photrexa and the KXL System is for the treatment of progressive keratoconus, a gradual thinning and distortion of the cornea. Boston-based Avedro said the treatment is […]
Ex-Insulet CEO DeSisto is new chief exec at MannKind | Personnel Moves
MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
Avedro CEO Muller is out | Personnel Moves
Avedro said CEO David Muller stepped down shortly after it closed a $32 million equity round last month, replaced on an interim basis by COO Brian Roberts, the former CFO at Insulet (NSDQ:PODD). Waltham-based Avedro said Muller left to “pursue other opportunities.” “On behalf of the board and all the Avedro employees, I want to thank […]
Avedro raises $32m
Avedro said today it closed a $32 million round of equity financing to support the global distribution of its KXL corneal cross-linking platform and commercialization of its Mosaic photorefractive intrastromal cross-linking system. The round was led by new investors InterWest Partners and OrbiMed and joined by several existing investors, Waltham, Mass.-based Avedro said. “The Avedro corneal cross-linking technology […]
Avedro wins Chinese approval for KXL eye treatment
Avedro said today it won Chinese Food and Drug Administration approval for its KXL cross-linking eye treatment device for treating keratoconus and post-lasic ectasia. Avedro said the clearance made the KXL system the 1st and only corneal coss-linking device to win approval in the People’s Republic of China. “As the 1st ophthalmic surgeon in China to use […]
- 1
- 2
- 3
- 4
- Next Page »
